Candesartan ameliorates brain inflammation associated with Alzheimer's disease.

Abstract:

AIMS:Alzheimer's disease (AD) pathology is associated with brain inflammation involving microglia and astrocytes. The renin-angiotensin system contributes to brain inflammation associated with AD pathology. This study aimed to investigate the role of candesartan, an angiotensin II type 1 receptor blocker, in modulation of glial functions associated with AD. METHODS:Focusing on the role of candesartan in glial inflammation, we evaluated inflammatory mediators' levels, secreted by lipopolysaccharide-induced microglia following candesartan treatment. Also, short-term intranasal candesartan effects on amyloid burden and microglial activation were investigated in 5 familial AD mice. RESULTS:Candesartan showed anti-inflammatory effects and shifted microglial activation toward a more neuroprotective phenotype. Candesartan decreased the lipopolysaccharide-induced nitric oxide synthase and cyclooxygenase-2 expression levels, which was accompanied by an induction of arginase-1 expression levels and enhanced Aβ1-42 uptake by microglia. Moreover, intranasally administered candesartan to AD mice model significantly reduced the amyloid burden and microglia activation in the hippocampus. CONCLUSIONS:These results thus shed light on the neuroprotective role of candesartan in the early stage of AD, which might relate to modulation of microglial activation states.

journal_name

CNS Neurosci Ther

authors

Torika N,Asraf K,Apte RN,Fleisher-Berkovich S

doi

10.1111/cns.12802

subject

Has Abstract

pub_date

2018-03-01 00:00:00

pages

231-242

issue

3

eissn

1755-5930

issn

1755-5949

journal_volume

24

pub_type

杂志文章
  • Head Transplantation in Mouse Model.

    abstract:AIMS:The mouse model of allo-head and body reconstruction (AHBR) has recently been established to further the clinical development of this strategy for patients who are suffering from mortal bodily trauma or disease, yet whose mind remains healthy. Animal model studies are indispensable for developing such novel surgic...

    journal_title:CNS neuroscience & therapeutics

    pub_type: 杂志文章

    doi:10.1111/cns.12422

    authors: Ren XP,Ye YJ,Li PW,Shen ZL,Han KC,Song Y

    更新日期:2015-08-01 00:00:00

  • Do stroke patients have an increased risk of developing suicidal ideation or dying by suicide? An overview of the current literature.

    abstract::Stroke is a leading cause of death that affects 15 million people worldwide each year. Increasing evidence suggests that stroke confers substantial risk for suicide and following a stroke, patients frequently develop poststroke depression, which is a well-established risk factor for suicide. In this overview of the cu...

    journal_title:CNS neuroscience & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1111/j.1755-5949.2012.00364.x

    authors: Pompili M,Venturini P,Campi S,Seretti ME,Montebovi F,Lamis DA,Serafini G,Amore M,Girardi P

    更新日期:2012-09-01 00:00:00

  • Protective effects of urinary trypsin inhibitor on vascular permeability following subarachnoid hemorrhage in a rat model.

    abstract:AIMS:Inflammation and apoptosis play important roles in increasing vascular permeability following subarachnoid hemorrhage (SAH). The objective of this study was to evaluate whether urinary trypsin inhibitor (UTI), a serine protease inhibitor, attenuates vascular permeability by its antiinflammatory and antiapoptotic e...

    journal_title:CNS neuroscience & therapeutics

    pub_type: 杂志文章

    doi:10.1111/cns.12122

    authors: Zhou N,Xu T,Bai Y,Prativa S,Xu JZ,Li K,Han HB,Yan JH

    更新日期:2013-09-01 00:00:00

  • Effects of combination therapy with levamlodipine and bisoprolol on stroke in rats.

    abstract:AIM:To examine the effects of combination with levamlodipine and bisoprolol on stroke in rats. METHODS:For acute study, Systolic blood pressure (SBP) and heart period (HP) were monitored in conscious stroke prone-spontaneously hypertensive rats (SHR-SP) and sinoaortic denervation (SAD) rats before and after intragastr...

    journal_title:CNS neuroscience & therapeutics

    pub_type: 杂志文章

    doi:10.1111/cns.12057

    authors: Gui H,Guo YF,Liu X,Zhang JM,Yang YL,Huang GZ,Liu JG

    更新日期:2013-03-01 00:00:00

  • Cerebrospinal fluid biomarkers in Alzheimer's disease and geriatric depression: preliminary findings from Brazil.

    abstract:AIMS:Depression is a highly prevalent disorder in the elderly and one of the risk factors for developing dementia. The present study involves patients with Alzheimer's disease (AD), geriatric major depressive disorder (MDD) and cognitively healthy controls aiming to compare baseline cerebrospinal fluid (CSF) biomarkers...

    journal_title:CNS neuroscience & therapeutics

    pub_type: 杂志文章

    doi:10.1111/j.1755-5949.2012.00311.x

    authors: Reis T,Brandão CO,Freire Coutinho ES,Engelhardt E,Laks J

    更新日期:2012-07-01 00:00:00

  • Lives in isolation: stories and struggles of low-income African American women with panic disorder.

    abstract::Research evidence points to the existence of racial-ethnic disparities in both access to and quality of mental health services for African Americans with panic disorder. Current panic disorder evaluation and treatment paradigms are not responsive to the needs of many African Americans. The primary individual, social, ...

    journal_title:CNS neuroscience & therapeutics

    pub_type: 杂志文章

    doi:10.1111/j.1755-5949.2009.00079.x

    authors: Johnson M,Mills TL,Deleon JM,Hartzema AG,Haddad J

    更新日期:2009-10-01 00:00:00

  • miR-181d-5p promotes neurite outgrowth in PC12 Cells via PI3K/Akt pathway.

    abstract:INTRODUCTION:miRNAs dysregulate in spinal cord injury (SCI) and have been demonstrated to play a crucial role in neurite outgrowth. However, the underlying mechanism remains elusive. In this study, we constructed a mouse model of SCI, extracted RNA from injured spinal cord tissue for the use of microarray assay. miR-18...

    journal_title:CNS neuroscience & therapeutics

    pub_type: 杂志文章

    doi:10.1111/cns.12761

    authors: Shen LM,Song ZW,Hua Y,Chao X,Liu JB

    更新日期:2017-11-01 00:00:00

  • Efforts of subthalamic nucleus deep brain stimulation on cognitive spectrum: From explicit to implicit changes in the patients with Parkinson's disease for 1 year.

    abstract:OBJECTIVE:To evaluate the cognitive function of Chinese patients with Parkinson's disease PD postsubthalamic nucleus deep brain stimulation (STN-DBS). METHODS:Cognitive function was assessed by neuropsychological methods in PD patients. Twenty matched healthy persons served as normal controls. t test, analysis of vari...

    journal_title:CNS neuroscience & therapeutics

    pub_type: 杂志文章

    doi:10.1111/cns.13392

    authors: You Z,Wu YY,Wu R,Xu ZX,Wu X,Wang XP

    更新日期:2020-09-01 00:00:00

  • Vagomimetic effects of fingolimod: physiology and clinical implications.

    abstract::Fingolimod is a sphingosine 1-phosphate (S1P) receptor modulator approved to treat relapsing-remitting multiple sclerosis (MS). Initiation of treatment with fingolimod has been found to produce transient bradycardia and/or slowing of atrioventricular impulse conduction in a small proportion of patients. This effect is...

    journal_title:CNS neuroscience & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1111/cns.12283

    authors: Vanoli E,Pentimalli F,Botto G

    更新日期:2014-06-01 00:00:00

  • Anticoagulation therapy is harmful to large-sized cerebellar infarction.

    abstract:AIM:Anticoagulants are commonly used to treat ischemic stroke. Its impact on cerebellar infarction has not been fully understood. METHODS:In the clinical study, we reviewed a consecutive series of patients with large-sized cerebellar infarction (diameter > 3 cm, n = 30) treated with or without anticoagulation. In anim...

    journal_title:CNS neuroscience & therapeutics

    pub_type: 杂志文章

    doi:10.1111/cns.12299

    authors: Zhang SQ,Wang W,Ma XL,Xia YY,Liu AJ

    更新日期:2014-09-01 00:00:00

  • Calcitonin gene-related peptide (CGRP): A novel target for Alzheimer's disease.

    abstract::Alzheimer's disease (AD) is leading cause of death among older characterized by neurofibrillary tangles, oxidative stress, progressive neuronal deficits, and increased levels of amyloid-β (Aβ) peptides. Cholinergic treatment could be the best suitable physiological therapy for AD. Calcitonin gene-related peptide (CGRP...

    journal_title:CNS neuroscience & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1111/cns.12696

    authors: Singh Y,Gupta G,Shrivastava B,Dahiya R,Tiwari J,Ashwathanarayana M,Sharma RK,Agrawal M,Mishra A,Dua K

    更新日期:2017-06-01 00:00:00

  • The impact of brain-derived neurotrophic factor Val66Met polymorphism on cognition and functional brain networks in patients with intractable partial epilepsy.

    abstract:INTRODUCTION:Medial temporal lobe epilepsy (mTLE) is the most common refractory focal epilepsy in adults. Around 30%-40% of patients have prominent memory impairment and experience significant postoperative memory and language decline after surgical treatment. BDNF Val66Met polymorphism has also been associated with co...

    journal_title:CNS neuroscience & therapeutics

    pub_type: 杂志文章

    doi:10.1111/cns.13003

    authors: Sidhu MK,Thompson PJ,Wandschneider B,Foulkes A,de Tisi J,Stretton J,Perona M,Thom M,Bonelli SB,Burdett J,Williams E,Duncan JS,Matarin M

    更新日期:2019-02-01 00:00:00

  • Therapeutic role of 5-HT1A receptors in the treatment of schizophrenia and Parkinson's disease.

    abstract::5-HT(1A) receptors have long been implicated in the pathogenesis and treatment of anxiety and depressive disorders. Recently, several lines of studies have revealed new insights into the therapeutic role of 5-HT(1A) receptors in treating schizophrenia and Parkinson's disease. Specifically, 5-HT(1A) receptors seem to b...

    journal_title:CNS neuroscience & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1111/j.1755-5949.2010.00211.x

    authors: Ohno Y

    更新日期:2011-02-01 00:00:00

  • Strategies for the use of Ginkgo biloba extract, EGb 761® , in the treatment and management of mild cognitive impairment in Asia: Expert consensus.

    abstract:BACKGROUND:Mild cognitive impairment (MCI) is a neurocognitive state between normal cognitive aging and dementia, with evidence of neuropsychological changes but insufficient functional decline to warrant a diagnosis of dementia. Individuals with MCI are at increased risk for progression to dementia; and an appreciable...

    journal_title:CNS neuroscience & therapeutics

    pub_type: 杂志文章

    doi:10.1111/cns.13536

    authors: Kandiah N,Chan YF,Chen C,Dasig D,Dominguez J,Han SH,Jia J,Kim S,Limpawattana P,Ng LL,Nguyen DT,Ong PA,Raya-Ampil E,Saedon N,Senanarong V,Setiati S,Singh H,Suthisisang C,Trang TM,Turana Y,Venketasubramanian N,Yon

    更新日期:2021-02-01 00:00:00

  • Role of serotonin in central dopamine dysfunction.

    abstract::The interaction between serotonin (5-HT) and dopamine (DA)-containing neurons in the brain is a research topic that has raised the interest of many scientists working in the field of neuroscience since the first demonstration of the presence of monoamine-containing neurons in the mid 1960. The bulk of neuroanatomical ...

    journal_title:CNS neuroscience & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1111/j.1755-5949.2010.00135.x

    authors: Di Giovanni G,Esposito E,Di Matteo V

    更新日期:2010-06-01 00:00:00

  • Sema7A, a brain immune regulator, regulates seizure activity in PTZ-kindled epileptic rats.

    abstract:AIMS:Semaphorin7A (Sema7A) plays an important role in the immunoregulation of the brain. In our study, we aimed to investigate the expression patterns of Sema7A in epilepsy and further explore the roles of Sema7A in the regulation of seizure activity and the inflammatory response in PTZ-kindled epileptic rats. METHODS...

    journal_title:CNS neuroscience & therapeutics

    pub_type: 杂志文章

    doi:10.1111/cns.13181

    authors: Deng J,Xu T,Yang J,Zhang KM,Li Q,Yu XY,Li R,Fu J,Jiang Q,Ma JX,Chen YM

    更新日期:2020-01-01 00:00:00

  • Ginsenosides and their CNS targets.

    abstract::Ginsenosides are a special group of triterpenoid saponins attributed to medical effects of ginseng. Therefore, they have been research targets over the last three decades to explain ginseng actions and a wealth of literature has been presented reporting on ginsenosides' effects on the human body. Recently, there is in...

    journal_title:CNS neuroscience & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1111/j.1755-5949.2010.00208.x

    authors: Radad K,Moldzio R,Rausch WD

    更新日期:2011-12-01 00:00:00

  • Olanzapine induced autophagy through suppression of NF-κB activation in human glioma cells.

    abstract:AIMS:Our laboratory previously reported that olanzapine treatment inhibited growth of glioma cell lines and hypothesized that autophagy may be involved in the proliferation inhibitory effects of olanzapine. However, the mechanisms of olanzapine-contributed autophagy activation are unclear. METHODS:The inhibitory effec...

    journal_title:CNS neuroscience & therapeutics

    pub_type: 杂志文章

    doi:10.1111/cns.13127

    authors: Zhu Y,Zhao YF,Liu RS,Xiong YJ,Shen X,Wang Y,Liang ZQ

    更新日期:2019-09-01 00:00:00

  • Hallucinations in neurodegenerative diseases.

    abstract::Patients with neurodegenerative disease frequently experience hallucinations and illusionary perceptions. As early symptoms, hallucinations may even have diagnostic relevance (i.e., for the diagnosis of Lewy Body Dementia). In the later course of the disease, hallucinations may appear as characteristic symptoms and of...

    journal_title:CNS neuroscience & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1111/j.1755-5949.2011.00247.x

    authors: Burghaus L,Eggers C,Timmermann L,Fink GR,Diederich NJ

    更新日期:2012-02-01 00:00:00

  • Machine learning models predict coagulopathy in spontaneous intracerebral hemorrhage patients in ER.

    abstract:AIMS:Coagulation abnormality is one of the primary concerns for patients with spontaneous intracerebral hemorrhage admitted to ER. Conventional laboratory indicators require hours for coagulopathy diagnosis, which brings difficulties for appropriate intervention within the optimal window. This study evaluates the possi...

    journal_title:CNS neuroscience & therapeutics

    pub_type: 杂志文章

    doi:10.1111/cns.13509

    authors: Zhu F,Pan Z,Tang Y,Fu P,Cheng S,Hou W,Zhang Q,Huang H,Sun Y

    更新日期:2020-11-28 00:00:00

  • Sunitinib produces neuroprotective effect via inhibiting nitric oxide overproduction.

    abstract:BACKGROUND:Sunitinib is an inhibitor of the multiple receptor tyrosine kinases (RTKs) for cancer therapy. Some sunitinib analogues could prevent neuronal death induced by various neurotoxins. However, the neuroprotective effects of sunitinib have not been reported. METHODS:Cerebellar granule neurons (CGNs) and SH-SY5Y...

    journal_title:CNS neuroscience & therapeutics

    pub_type: 杂志文章

    doi:10.1111/cns.12203

    authors: Cui W,Zhang ZJ,Hu SQ,Mak SH,Xu DP,Choi CL,Wang YQ,Tsim WK,Lee MY,Rong JH,Han YF

    更新日期:2014-03-01 00:00:00

  • A brain network model for depression: From symptom understanding to disease intervention.

    abstract::Understanding the neural substrates of depression is crucial for diagnosis and treatment. Here, we review recent studies of functional and effective connectivity in depression, in terms of functional integration in the brain. Findings from these studies, including our own, point to the involvement of at least four net...

    journal_title:CNS neuroscience & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1111/cns.12998

    authors: Li BJ,Friston K,Mody M,Wang HN,Lu HB,Hu DW

    更新日期:2018-11-01 00:00:00

  • Cannabidiol: a promising drug for neurodegenerative disorders?

    abstract::Neurodegenerative diseases represent, nowadays, one of the main causes of death in the industrialized country. They are characterized by a loss of neurons in particular regions of the nervous system. It is believed that this nerve cell loss underlies the subsequent decline in cognitive and motor function that patients...

    journal_title:CNS neuroscience & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1111/j.1755-5949.2008.00065.x

    authors: Iuvone T,Esposito G,De Filippis D,Scuderi C,Steardo L

    更新日期:2009-01-01 00:00:00

  • Mitochondrial dysfunction and cerebral metabolic abnormalities in patients with mitochondrial encephalomyopathy subtypes: Evidence from proton MR spectroscopy and muscle biopsy.

    abstract:AIMS:Accumulated evidence indicates that cerebral metabolic features, evaluated by proton magnetic resonance spectroscopy (1 H-MRS), are sensitive to early mitochondrion dysfunction associated with mitochondrial encephalomyopathy (ME). The metabolite ratios of lactate (lac)/Cr, N-acetyl aspartate (NAA)/creatine (Cr), t...

    journal_title:CNS neuroscience & therapeutics

    pub_type: 杂志文章

    doi:10.1111/cns.12714

    authors: Niu FN,Meng HL,Chang LL,Wu HY,Li WP,Liu RY,Wang HT,Zhang B,Xu Y

    更新日期:2017-08-01 00:00:00

  • Rosiglitazone polarizes microglia and protects against pilocarpine-induced status epilepticus.

    abstract:AIMS:Activated microglia have been found in the forebrains and hippocampi of temporal lobe epilepsy (TLE) patients and status epileptic (SE) animal models. The peroxisome proliferator-activated receptor γ (PPAR γ) agonist rosiglitazone has been shown to prevent microglial activation. However, its role in pilocarpine-in...

    journal_title:CNS neuroscience & therapeutics

    pub_type: 杂志文章

    doi:10.1111/cns.13265

    authors: Peng J,Wang K,Xiang W,Li Y,Hao Y,Guan Y

    更新日期:2019-12-01 00:00:00

  • Development and validation of a new score for predicting functional outcome of neurocritically ill patients: The INCNS score.

    abstract:AIMS:To develop and validate a novel score for prediction of 3-month functional outcome in neurocritically ill patients. METHODS:The development of the novel score was based on two widely used scores for general critical illnesses (Acute Physiology and Chronic Health Evaluation II, APACHE II; Simplified Acute Physiolo...

    journal_title:CNS neuroscience & therapeutics

    pub_type: 杂志文章

    doi:10.1111/cns.13134

    authors: Gao Q,Yuan F,Yang XA,Zhu JW,Song L,Bi LJ,Jiao ZY,Kang XG,Yang F,Jiang W

    更新日期:2020-01-01 00:00:00

  • Potential mechanisms involved in the prevention of neurodegenerative diseases by lithium.

    abstract::Lithium is a monovalent cation that was introduced in 1949 by John Cade for the treatment of bipolar disorder. Clinical reports and subsequent studies confirmed this application and the beneficial effects of this compound. However, over the last 15 years, various authors have also demonstrated the neuroprotective effe...

    journal_title:CNS neuroscience & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1111/j.1755-5949.2009.00086.x

    authors: Camins A,Verdaguer E,Junyent F,Yeste-Velasco M,Pelegrí C,Vilaplana J,Pallás M

    更新日期:2009-01-01 00:00:00

  • Endothelial progenitor cells contribute to neointima formation in rabbit elastase-induced aneurysm after flow diverter treatment.

    abstract:AIMS:Endothelial progenitor cells (EPCs) are involved in vascular repair and homeostasis after vascular injuries. In this study, we aimed to explore whether bone marrow (BM)-derived EPCs contribute to neointima formation and reendothelialization in rabbit elastase-induced aneurysm after flow diverter treatment. METHOD...

    journal_title:CNS neuroscience & therapeutics

    pub_type: 杂志文章

    doi:10.1111/cns.12086

    authors: Li ZF,Fang XG,Yang PF,Huang QH,Zhao WY,Liang C,Zhao R,Liu JM

    更新日期:2013-05-01 00:00:00

  • Limited versus extended cocaine intravenous self-administration: Behavioral effects and electrophysiological changes in insular cortex.

    abstract:AIMS:Limited vs extended drug exposure has been proposed as one of the key factors in determining the risk of relapse, which is the primary characteristic of addiction behaviors. The current studies were designed to explore the related behavioral effects and neuronal alterations in the insular cortex (IC), an important...

    journal_title:CNS neuroscience & therapeutics

    pub_type: 杂志文章

    doi:10.1111/cns.13469

    authors: Luo YX,Huang D,Guo C,Ma YY

    更新日期:2021-02-01 00:00:00

  • Clinical Impact of Not Achieving Recommended Dose on Duration of Atomoxetine Treatment in Adults with Attention-Deficit/Hyperactivity Disorder.

    abstract:AIM:To compare atomoxetine (ATX) length of therapy (LoT) among adults with ADHD who reached the recommended dose of 80 mg/day (ATX ≥ 80) versus those who did not (ATX < 80) analyzed separately in patients prescribed ATX as monotherapy (mono) and in combination with other ADHD medications (combo). METHODS:This was a re...

    journal_title:CNS neuroscience & therapeutics

    pub_type: 杂志文章

    doi:10.1111/cns.12595

    authors: Clemow DB,Nyhuis AW,Robinson RL

    更新日期:2016-12-01 00:00:00